Crossmark

Getting it wrong most of the time? Comparing trialists’ choice of primary outcome with what patients and health professionals want

Published Online: 2022-06-27

Published Print: 2022-12

Authors

Treweek, Shaun http://orcid.org/0000-0002-7239-7241
Miyakoda, Viviane

Burke, Dylan

Shiely, Frances
License Information

Text and Data Mining valid from 2022-06-27

Version of Record valid from 2022-06-27
More Information

Article History

Received: 16 November 2021

Accepted: 25 April 2022

First Online: 27 June 2022

Declarations

:

: Ethical approval for the nephrology study was granted by the Clinical Research Ethics Committee of the Cork Teaching Hospitals at University College Cork (ECM 4 (i) 10/09/2019 & ECM 3 (gg) 12/11/19). All participants completed and signed an informed consent form. For the breast cancer work done in the UK, the patient views (and health professionals’ views for that matter) were intended to support the design of future trials, which puts the consultation in the area of patient and public involvement (PPI) rather than research participation and PPI does not require ethical approval in the UK. Nevertheless, by completing the survey, all participants gave their implied consent to take part.

: Not applicable.

: ST is an Editor-in-Chief of <i>Trials</i>. The other authors declare that they have no competing interests.

Document is current